Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 22;14:17588359221126149. doi: 10.1177/17588359221126149

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2022

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Partitioned survival curves for the (a) HRd and (b) overall ITT populations.

TOX included grade ⩾2 AEs of interest (fatigue or asthenia, nausea, vomiting, abdominal pain, and abdominal bloating). HRd and overall ITT populations had a maximum PFS of 27.8 months.

AE, adverse event; HRd, homologous recombination deficient; ITT, intention-to-treat; PFS, progression-free survival; TOX, time before PFS during which patients experienced grade ⩾2 AEs; TWiST, time without symptoms of disease or toxicity.